Search Results for 'Noac Noacs'

Noac Noacs published presentations and documents on DocSlides.

What You Didn't Know About AF and Renal Dysfunction

lois-ondreau
25 Slides

Percentage of Strokes Attributable to AF Increase...

Update on the New Oral Anticoagulants

sherrill-nordquist
39 Slides

Eliot Williams, MD PhD. Division of Hematology &a...

Alexander G

min-jolicoeur
35 Slides

G. . Turpie. Professor Emeritus of Medicine. McM...

Centuries of Service

faustina-dinatale
22 Slides

: The 100. th. Anniversary of the Order of the A...

Reversal Agent vs Supportive Care for NOAC-Related Bleeds:

cheryl-pisano
18 Slides

. What Do the Data Suggest? . Testing for NOAC L...

Direct Oral Anticoagulants

debby-jeon
53 Slides

Eliot Williams, MD PhD. Division of Hematology &a...

An Update on Reversal Agents for NOACs: Where Are

briana-ranney
17 Slides

We Now?. Moderator. Christian T. Ruff, MD, MPH. A...

Update in the Perioperative and Emergency Management of Nov

danika-pritchard
47 Slides

Annelise Gallien, MD FRCPC. Moncton City Hospital...

Stroke or systemic embolic events in large NOAC trials, vs

faustina-dinatale
3 Slides

Ruff . et al. ., The Lancet, 2013. Ruff . et al. ...

Warfarin Important Drug-Drug Interactions With NOACs

trish-goza
0 Slides

Comparative Pharmacology. Factors Related to Adhe...

Managing Bleeds in Patients Anticoagulated With Warfarin and Other Agents

danika-pritchard
0 Slides

Introduction/Overview . VKA-Associated Bleeding: ...

Dos and Don’ts for High-Risk Elderly Patients With AF

ellena-manuel
0 Slides

Why Anticoagulate?. Anticoagulate Even in High-Ri...

Anticoagulants in Interventional Cardiology:

trish-goza
0 Slides

Overview of Anticoagulation in . Interventional C...

- ARROWMAN 101: Looking in the Rearview Mirror

tawny-fly
0 Slides

Why Do We Have a Rearview Mirror?. OA MILE MARKER...

A New Era for NOACs: Program Goals

danika-pritchard
0 Slides

Evidence For NOACs in Patients With NVAF-PCI. PIO...

NOACs vs. warfarin: Pros and Cons for Patients and Providers to Consider

debby-jeon
0 Slides

Advantages of NOACs. No INR monitoring required. ...

Through Thick and Thin Program Goal

phoebe-click
0 Slides

AF and Weight. Facts About Overweight and Obesity...

Non-vitamin K antagonist oral anticoagulants

tawny-fly
0 Slides

(NOACs) . YOUR FACILITY. Presenter. Month YYYY. S...

TAVI with atrial fibrillation

kittie-lecroy
21 Slides

TAVI with atrial fibrillation : which antithro...

The Best of Both Worlds in CAD/PAD:

alexa-scheidler
16 Slides

The Best of Both Worlds in CAD/PAD: The Emerging...

Management of Atrial Fibrillation, Stroke, and Bleeding

natalia-silvester
33 Slides

Meta-Analysis of NOACs vs Warfarin. RCT vs Real-W...

Managing Atrial Fibrillation at a population based level

walsh
57 Slides

Clair . Huckerby. Pharmaceutical Adviser- Medicine...

PRAGUE-17 : Three-Year

LoveBug
21 Slides

Outcomes. . From. A . Randomized. Trial . of. ...

Review on NOACs Studies Dr.

BlessedBeyondMeasure
37 Slides

Kourosh. . Sadeghi. Tehran University of medical ...

P erioperative management of anticoagulated geriatric patients with

TinyTeddy
20 Slides

hip fractures. Dr Linda Xu . linda.xu@health.nsw.g...